Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About APTX

Aptinyx Inc.is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders.Aptinyxhas a platform for discovery of novel compounds that work through a unique mechanism to modulate rather than block or over-activate NMDA receptors and enhance synaptic plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder (PTSD), and cognitive impairment associated with Parkinson's disease.Aptinyxis also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

APTX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS Invesco Russell 2000 Equal Weight ETF 20.8 M 2.08E+07 1,977 1977 0.03% 0.00025 5 K 5105
IWC iShares Microcap ETF 912.4 M 9.12448E+08 1,449 1449 0.08% 0.0008 781 K 780969
IWM iShares Russell 2000 ETF 44.5 B 4.44813E+10 2,022 2022 0.02% 0.0002 6.8 M 6825580
IWN iShares Russell 2000 Value ETF 9.4 B 9.39433E+09 1,373 1373 0.01% 0.0001 481 K 481366
IWO iShares Russell 2000 Growth ETF 9.0 B 8.98678E+09 1,240 1240 0.03% 0.0003 2.3 M 2331540
IWV iShares Russell 3000 ETF 8.4 B 8.38911E+09 3,006 3006 0.0% 0 95 K 95455
URTY ProShares UltraPro Russell2000 108.8 M 1.08826E+08 2,033 2033 0.0% 2.78394E-05 10 K 10233
UWM ProShares Ultra Russell2000 162.8 M 1.62825E+08 2,033 2033 0.01% 6.11548E-05 21 K 21280

Wait, Before You Leave...